88
edits
Changes
Jump to navigation
Jump to search
Line 9:
Line 9: + + +
HPV Vaccine
[[Merck]] has developed a [[vaccine]] against the four most prevalent sexually transmitted strains of HPV; see [[Gardasil]]. [[GlaxoSmithKline]] later released its own vaccine, Cervarix, which protects against the two most prevalent high risk strains. Both vaccines are manufactured using recombinant viral capsid proteins.
[[Merck]] has developed a [[vaccine]] against the four most prevalent sexually transmitted strains of HPV; see [[Gardasil]]. [[GlaxoSmithKline]] later released its own vaccine, Cervarix, which protects against the two most prevalent high risk strains. Both vaccines are manufactured using recombinant viral capsid proteins.
==HPV Vaccine==
A new study looking at the prevalence of human papillomavirus (HPV) infections in girls and women before and after the introduction of the HPV vaccine shows a significant reduction in vaccine-type HPV in U.S. teens. The study, published in [the June issue of] The Journal of Infectious Diseases reveals that since the vaccine was introduced in 2006, vaccine-type HPV prevalence decreased 56 percent among female teenagers 14-19 years of age. <ref>http://www.cdc.gov/media/releases/2013/p0619-hpv-vaccinations.html</ref>
==References==
==References==